Recent News

April 20, 2020 – Read Bayer’s Statement in response to motions to intervene filed in Rural Coalition et al. v. U.S. Environmental Protection Agency et al. and a parallel case brought by the Natural Resources Defense Council, cases which challenge EPA’s Interim Registration Review Decision on glyphosate here.

April 2, 2020 – Read Bayer’s latest statement on mediation in the Roundup litigation in light of COVID-19 here.

February 12, 2020 – A nationwide coalition of agricultural producers and business entities that collectively represent a substantial segment of U.S. agriculture filed in the Eastern District of California in support of their motion for summary judgment in the case against the California Attorney General regarding the state’s cancer warning requirement for products containing glyphosate under California’s Proposition 65. Read the filing here.

February 11, 2020 – Monsanto filed a supplemental appeal brief in the Johnson case in the Court of Appeal of the State of California (First Appellate District, Division One). Read the brief here.

February 7, 2020 – Monsanto filed its opening appeal brief in the Pilliod case, urging the California Court of Appeal to reverse the verdict in the case. Read the opening appeal brief here, motion for judicial notice here, and Bayer’s press release here.


This site provides information about litigation against Monsanto involving glyphosate-based products (i.e., various Roundup®-branded products.) Bayer has created this site to provide education and resources related to the litigation to media, stakeholders and others with interests relevant to this litigation.

For more information about the litigation, please contact us at

Fast Facts on Glyphosate and
Glyphosate-Based Herbicides

  • Long history of safe use: For more than 40 years, farmers – as well as governments, gardeners, and other users – have depended on glyphosate as an efficient and cost-effective tool that can be used safely as directed to control weeds.

  • Conservation benefits: Glyphosate-based herbicides help farmers deliver crops to markets while promoting sustainable farming by reducing soil tillage, soil erosion and carbon emissions.
  • Extensive scientific backing: There is an extensive body of research on glyphosate and Monsanto/Bayer’s glyphosate-based herbicides, including more than 100 studies EPA considered relevant to its cancer risk analysis and more than 800 safety studies overall submitted to regulators, concluding that Bayer’s glyphosate-based herbicides can be used safely as directed and that glyphosate is not carcinogenic.
  • Not carcinogenic: The largest and most recent epidemiology studies, which are the most relevant research for assessing exposure effects in the human population, each found that there was no association between glyphosate-based herbicides and NHL overall in real-world use when adjusted for the use of other pesticides. These include the 2018 independent National Cancer Institute-supported Agricultural Health Study, which followed over 50,000 pesticide applicators for more than 20 years; the 2019 Leon Agricoh Consortium study, which included over 300,000 pesticide applicators; and the 2019 North American Pooled Project, which combined data previously reported in earlier case control studies.

  • Favorable conclusions of regulators and international agencies around the world: The conclusions of leading health authorities around the world, including the U.S. Environmental Protection Agency (EPA), European Food Safety Authority (EFSA), European Chemicals Agency (ECHA), German BfR, and Australian, Canadian, Korean, New Zealand and Japanese regulatory authorities, as well as the Joint FAO/WHO Meeting on Pesticide Residues (JMPR), continue to support the safety of glyphosate‐based products when used as directed and that glyphosate is not carcinogenic. In January 2020, the EPA’s latest interim registration review decision on glyphosate reaffirmed that it “did not identify any human health risks from exposure to glyphosate.”

Recent Media Statements